BNTX

#528
BioNTech SE American Depositary Share
98.41 USD
+1.77%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
98.41
98.41
Годовой диапазон
79.52
123.98
Дневное изменение
+1.77%
Месячное изменение
+6.97%
6-месячное изменение
-3.97%
Годовое изменение
-3.79%
Предыдущее закрытие
96.70
Открыть
98.41
Bid
Ask
Минимум
98.41
High
98.41
Объем
118
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
Отчет о доходах Баланс Денежный поток
Значение 202020212022202320242025 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Новости